ABT-888 [clinicaltrials_resource:13f50414e6391beb3d8a728aa7fe1cf1]
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas [clinicaltrials:NCT00553189]A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors [clinicaltrials:NCT00994071]ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems [clinicaltrials:NCT01419548]ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer [clinicaltrials:NCT01445522]
intervention [clinicaltrials_vocabulary:intervention]
ABT-888 [clinicaltrials_resource:13f50414e6391beb3d8a728aa7fe1cf1]
Bio2RDF identifier
13f50414e6391beb3d8a728aa7fe1cf1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:13f50414e6391beb3d8a728aa7fe1cf1
intervention desc [clinicaltrials_vocabulary:intervention-desc]
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:13f50414e6391beb3d8a728aa7fe1cf1
title
ABT-888
@en
type
label
ABT-888 [clinicaltrials_resource:13f50414e6391beb3d8a728aa7fe1cf1]
@en